Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 1, 2009, Pages 47-54

  Chieng, Norman ^a   Aaltonen, Jaakko ^a   Saville, Dorothy ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Amorphous state; Ball milling; Binary mixture; DRIFTS; DSC; Indomethacin; Ranitidine hydrochloride; Stability; XRPD

Indexed keywords

AMIDE; CARBONYL DERIVATIVE; CARBOXYLIC ACID; INDOMETACIN; NITRO DERIVATIVE; RANITIDINE;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSE REFLECTANCE INFRARED FOURIER TRANSFORM SPECTROSCOPY; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG STABILITY; DRUG STORAGE; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; X RAY POWDER DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG STABILITY; DRUG STORAGE; HISTAMINE H2 ANTAGONISTS; INDOMETHACIN; RANITIDINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS; X-RAY DIFFRACTION;

EID: 57349179076     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.06.022     Document Type: Article

References (35)

1. Andronis V., and Zografi G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non-Cryst. Solids 271 (2000) 236-248
2. Crowley K., and Zografi G. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci. 92 (2001) 492-507
3. Tong P., and Zografi G. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid. Pharm. Res. 16 (1999) 1186-1192
4. The Merck Index, 11, Merck & Co., Inc., New Jersey, 1989.
5. Ehsanullah R.S., Page M.C., Tildesley G., and Wood J.R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br. Med. J. 22 (1988) 1017-1021
6. Pratiwi D., Fawcett J.P., Gordon K.C., and Rades T. Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis. Eur. J. Pharm. Biopharm. 54 (2002) 337-341
7. Madan T., and Kakkar A.P. Preparation and characterization of ranitidine-HCl crystals. Drug Dev. Ind. Pharm. 20 (1994) 1571-1588
8. Agatonovic-Kustrin S., Wu V., Rades T., Saville D., and Tucker I.G. Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride. Int. J. Pharm. 184 (1999) 107-114
9. Mirmehrabi M., Rohani S., Murthy K.S.K., and Radatus B. Characterization of tautomeric forms of ranitidine hydrochloride: thermal analysis, solid-state NMR, X-ray. J. Cryst. Growth 260 (2004) 517-526
10. Chieng N., Zujovic Z., Bowmaker G., Rades T., and Saville D. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1. Int. J. Pharm. 327 (2006) 35-44
11. Bernstein J. Polymorphism in Molecular Crystals (2002), Oxford University Press, UK
12. Shen J., Lee D., and Mckeag R. Bioequivalence of two forms of ranitidine. NZ Pharm. 15 (1995) 24
13. Bawazir S.A., Gouda M.W., and El-Sayed Y.M. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Int. J. Clin. Pharm. 36 (1998) 270-274
14. Hilden L.R., and Morris K.R. Physics of amorphous solids. J. Pharm. Sci. 93 (2004) 3-12
15. Hancock B., and Parks M. What is the true solubility advantage for amorphous pharmaceuticals. Pharm. Res. 17 (2000) 397-404
16. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 48 (2001) 27-42
17. Watanabe T., Ohno I., Wakiyama N., Kusai A., and Senna M. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture. Int. J. Pharm. 241 (2002) 103-111
18. Crowley K.J., and Zografi G. The effect of low concentration of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state. Pharm. Res. 20 (2003) 1417-1422
19. Ambike A.A., Mahadik K.R., and Paradkar A. Stability study of amorphous valdecoxib. Int. J. Pharm. 282 (2004) 151-162
20. g drug. Powder Technol. 167 (2006) 20-25
21. Patterson J.E., James M.B., Forster A.H., Lancaster R.W., Butler J.M., and Rades T. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int. J. Pharm. 336 (2007) 22-34
22. Yamamura S., Momose Y., Takahashi K., and Nagatani S. Solid-state interaction between cimetidine and naproxen. Drug Stabil. 1 (1996) 173-178
23. Yamamura S., Gotoh H., Sakamoto Y., and Momose Y. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system. Eur. J. Pharm. Biopharm. 49 (2000) 259-265
24. Yamamura S., Gotoh H., Sakamoto Y., and Momose Y. Physicochemical properties of amorphous salt of cimetidine and diflunisal system. Int. J. Pharm. 241 (2002) 213-221
25. Chieng N., Rades T., and Saville D. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling. Eur. J. Pharm. Biopharm. 68 (2008) 771-780
26. Schneider H.A. The Gordon-Taylor equation. Additivity and interaction in compatible polymer blend. Macromol. Chem. Phys. 189 (1988) 1941-1955
27. Chen X., Griesser U.J., Te R.L., Pfeiffer R.R., Morris K.R., Stowell J.G., and Byrn S.R. Analysis of the acid-base reaction between solid indomethacin and sodium bicarbonate using infrared spectroscopy, X-ray powder diffraction, and solid-state nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 38 (2005) 670-677
28. Florey K. Analytical Profiles of Drug Substances (1984), Academic Press, New York
29. Taylor L.S., and Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
30. Pimentel G.C., and McClellan A.C. The Hydrogen Bond (1960), W.H. Freeman and Company, San Francisco
31. Florey K. Analytical Profiles of Drug Substances (1986), Academic Press, New York
32. Colthup N.B., Daly L.H., and Wiberley S.E. Introduction to Infrared and Raman Spectroscopy. third ed. (1990), Academic Press, Inc., San Diego
33. Ishida T., In Y., and Inoue M. Structure of ranitidine hydrochloride. Acta Crystallogr. C C46 (1990) 1893-1896
34. Yoshioka M., Hancock B.C., and Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83 (1994) 1700-1705
35. Jayasankar A., Somwangthanaroj A., Shao Z., and Rodríguez-Hornedo N. Cocrystal formation during cogrinding and storage is mediated by amorphous phase. Pharm. Res. 23 (2006) 2381-2392